Investment Summary

Aqueous Health Holdings Invests In Principle Diagnostics

On July 2, 2025, Aqueous Health Holdings invested in life science company Principle Diagnostics

Investment Highlights
  • This is Aqueous Health Holdings’ 1st transaction in the Life Science sector.
  • This is Aqueous Health Holdings’ 1st transaction in the United States.
  • This is Aqueous Health Holdings’ 1st transaction in Pennsylvania.

Investment Summary

Date 2025-07-02
Target Principle Diagnostics
Sector Life Science
Investor(s) Aqueous Health Holdings
Deal Type Stake Purchase
Advisor(s) Berkery, Noyes & Co. (Financial)
Gordon Feinblatt (Legal)

Target

Principle Diagnostics

Bethlehem, Pennsylvania, United States
Principle Diagnostics provides toxicology, molecular, and genetic testing services to a broad base of consumers, patients, providers, and other laboratories. Principle Diagnostics was founded in 2015 and is based in Bethlehem, Pennsylvania.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Aqueous Health Holdings

Phoenix, Arizona, United States

Category Company
Sector Life Science
DESCRIPTION

Aqueous Health Holdings is a healthcare diagnostics company that focuses on delivering diagnostic testing and health management solutions to consumers, patients, providers, employers, and insurers. Aqueous Health Holdings is based in Phoenix, Arizona.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1